Arteaga CL - Search Results

1

Hyperactivation of TORC1 Drives Resistance to the Pan-HER Tyrosine Kinase Inhibitor Neratinib in HER2-Mutant Cancers.

Sudhan DR, Guerrero-Zotano A, Won H, González Ericsson P, Servetto A, Huerta-Rosario M, Ye D, Lee KM, Formisano L, Guo Y, Liu Q, Kinch LN, Red Brewer M, Dugger T, Koch J, Wick MJ, Cutler RE Jr, Lalani AS, Bryce R, Auerbach A, Hanker AB, Arteaga CL. Sudhan DR, et al. Among authors: arteaga cl. Cancer Cell. 2020 Feb 10;37(2):183-199.e5. doi: 10.1016/j.ccell.2019.12.013. Epub 2020 Jan 23. Cancer Cell. 2020. PMID: 31978326 Free PMC article.

2

Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.

Arteaga CL, Coffey RJ Jr, Dugger TC, McCutchen CM, Moses HL, Lyons RM. Arteaga CL, et al. Cell Growth Differ. 1990 Aug;1(8):367-74. Cell Growth Differ. 1990. PMID: 2177634

3

Ligand-like effects induced by anti-c-erbB-2 antibodies do not correlate with and are not required for growth inhibition of human carcinoma cells.

Shawver LK, Mann E, Elliger SS, Dugger TC, Arteaga CL. Shawver LK, et al. Among authors: arteaga cl. Cancer Res. 1994 Mar 1;54(5):1367-73. Cancer Res. 1994. PMID: 7907001

4

p185c-erbB-2 signal enhances cisplatin-induced cytotoxicity in human breast carcinoma cells: association between an oncogenic receptor tyrosine kinase and drug-induced DNA repair.

Arteaga CL, Winnier AR, Poirier MC, Lopez-Larraza DM, Shawver LK, Hurd SD, Stewart SJ. Arteaga CL, et al. Cancer Res. 1994 Jul 15;54(14):3758-65. Cancer Res. 1994. PMID: 7913407

5

Evidence for a positive role of transforming growth factor-beta in human breast cancer cell tumorigenesis.

Arteaga CL, Dugger TC, Winnier AR, Forbes JT. Arteaga CL, et al. J Cell Biochem Suppl. 1993;17G:187-93. doi: 10.1002/jcb.240531134. J Cell Biochem Suppl. 1993. PMID: 8007696

6

Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein.

Arteaga CL, Hurd SD, Dugger TC, Winnier AR, Robertson JB. Arteaga CL, et al. Cancer Res. 1994 Sep 1;54(17):4703-9. Cancer Res. 1994. PMID: 8062268

7

The multifunctional role of transforming growth factor (TGF)-beta s on mammary epithelial cell biology.

Arteaga CL, Dugger TC, Hurd SD. Arteaga CL, et al. Breast Cancer Res Treat. 1996;38(1):49-56. doi: 10.1007/BF01803783. Breast Cancer Res Treat. 1996. PMID: 8825122 Review.

8

Blockade of transforming growth factor-beta signaling does not abrogate antiestrogen-induced growth inhibition of human breast carcinoma cells.

Koli KM, Ramsey TT, Ko Y, Dugger TC, Brattain MG, Arteaga CL. Koli KM, et al. Among authors: arteaga cl. J Biol Chem. 1997 Mar 28;272(13):8296-302. doi: 10.1074/jbc.272.13.8296. J Biol Chem. 1997. PMID: 9079651 Free article.

9

Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-beta.

Arteaga CL, Koli KM, Dugger TC, Clarke R. Arteaga CL, et al. J Natl Cancer Inst. 1999 Jan 6;91(1):46-53. doi: 10.1093/jnci/91.1.46. J Natl Cancer Inst. 1999. PMID: 9890169

10

Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells.

Kurokawa H, Lenferink AE, Simpson JF, Pisacane PI, Sliwkowski MX, Forbes JT, Arteaga CL. Kurokawa H, et al. Among authors: arteaga cl. Cancer Res. 2000 Oct 15;60(20):5887-94. Cancer Res. 2000. PMID: 11059787

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

425 results

Search Page

Filters